48,466
edits
(18 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{ Infobox diagnosis | {{ Infobox diagnosis | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Image = | | Image = Lung squamous carcinoma -- intermed mag.jpg | ||
| Width = | | Width = | ||
| Caption = Squamous cell carcinoma of the lung. [[ | | Caption = Squamous cell carcinoma of the lung. [[H&E stain]]. | ||
| Synonyms = squamous carcinoma of the lung | | Synonyms = squamous carcinoma of the lung | ||
| Micro = | | Micro = | ||
Line 9: | Line 9: | ||
| LMDDx = [[lung adenocarcinoma]], [[non-small cell lung carcinoma]], metastatic [[squamous cell carcinoma]], others | | LMDDx = [[lung adenocarcinoma]], [[non-small cell lung carcinoma]], metastatic [[squamous cell carcinoma]], others | ||
| Stains = | | Stains = | ||
| IHC = p40 +ve, p63 +ve, TTF-1 -ve, CK7 -ve | | IHC = [[p40]] +ve, [[p63]] +ve, [[TTF-1]] -ve, CK7 -ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
Line 15: | Line 15: | ||
| Gross = | | Gross = | ||
| Grossing = | | Grossing = | ||
| Staging = [[lung cancer staging]] | |||
| Site = [[lung]] - see [[lung tumours]] | | Site = [[lung]] - see [[lung tumours]] | ||
| Assdx = | | Assdx = | ||
Line 45: | Line 46: | ||
==Gross== | ==Gross== | ||
* | *Lung mass - usually centrally located, i.e. associated with a large airway. | ||
===Image=== | ===Image=== | ||
Line 58: | Line 59: | ||
*+/-Small nucleolus. | *+/-Small nucleolus. | ||
*Intracellular bridges - classic. | *Intracellular bridges - classic. | ||
Note: | |||
*[[Lymphovascular invasion]] (LVI) is relatively common in small tumours. In one series of NSLC tumours less than 2 cm the prevalence of LVI was 16%.<ref>{{cite journal |author=Tao H, Hayashi T, Sano F, ''et al.'' |title=Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller |journal=J. Surg. Res. |volume=185 |issue=1 |pages=250–4 |year=2013 |month=November |pmid=23830361 |doi=10.1016/j.jss.2013.05.104 |url=}}</ref> | |||
**Unlike in [[lung adenocarcinoma]], LVI in lung SCC does ''not'' seem to increase the risk of distant metastases and death.<ref name=pmid22617241>{{cite journal |author=Higgins KA, Chino JP, Ready N, ''et al.'' |title=Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy |journal=J Thorac Oncol |volume=7 |issue=7 |pages=1141–7 |year=2012 |month=July |pmid=22617241 |doi=10.1097/JTO.0b013e3182519a42 |url=}}</ref> | |||
DDx: | DDx: | ||
Line 63: | Line 68: | ||
*[[Adenocarcinoma of the lung]]. | *[[Adenocarcinoma of the lung]]. | ||
*[[Non-small cell lung carcinoma]] - diagnosis should be avoided if possible. | *[[Non-small cell lung carcinoma]] - diagnosis should be avoided if possible. | ||
*[[Small cell carcinoma of the lung]] - for ''basaloid squamous cell carcinoma''. | |||
===Grading=== | |||
There is no consensus on how grading of lung SCC should be done; however, a three tiered system is suggested in the CAP protocol,<ref name=cap_protocol_v3400>URL: [http://www.cap.org/ShowProperty?nodePath=/UCMCon/Contribution%20Folders/WebContent/pdf/cp-lung-16protocol-3400.pdf http://www.cap.org/ShowProperty?nodePath=/UCMCon/Contribution%20Folders/WebContent/pdf/cp-lung-16protocol-3400.pdf]. Version: 3.4.0.0. Accessed on: 23 March 2016.</ref> and some older data is suggestive that such a system for lung SCC can be predictive.<ref name=pmid7092385>{{Cite journal | last1 = Chung | first1 = CK. | last2 = Zaino | first2 = R. | last3 = Stryker | first3 = JA. | last4 = O'Neill | first4 = M. | last5 = DeMuth | first5 = WE. | title = Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis. | journal = Ann Thorac Surg | volume = 33 | issue = 6 | pages = 599-604 | month = Jun | year = 1982 | doi = | PMID = 7092385 }}</ref> | |||
The grading system loosely defined by the CAP protocol (version 3.4.0.0):<ref name=cap_protocol_v3400/> | |||
*Grade 1 (well differentiated) - extensive keratinization. | |||
*Grade 2 (moderately differentiated) - some keratinization. | |||
*Grade 3 (poorly differentiated) - no/little keratinization. | |||
===Images=== | |||
<gallery> | |||
Image: Lung squamous carcinoma -- very low mag.jpg | Lung SCC - very low mag. (WC) | |||
Image: Lung squamous carcinoma -- low mag.jpg | Lung SCC - low mag. (WC) | |||
Image: Lung squamous carcinoma -- intermed mag.jpg | Lung SCC - intermed. mag. (WC) | |||
Image: Lung squamous carcinoma -- high mag.jpg | Lung SCC - high mag. (WC) | |||
Image: Lung squamous carcinoma - alt -- low mag.jpg | Lung SCC - low mag. (WC) | |||
Image: Lung squamous carcinoma - alt -- intermed mag.jpg | Lung SCC - intermed. mag. (WC) | |||
</gallery> | |||
====Cytology==== | |||
<gallery> | |||
Image: Squamous carcinoma lung cytology.gif | Lung SCC - cytology. (WC) | |||
</gallery> | |||
==IHC== | ==IHC== | ||
Line 75: | Line 103: | ||
*TTF-1 -ve. | *TTF-1 -ve. | ||
**Positive in [[adenocarcinoma of the lung]]. | **Positive in [[adenocarcinoma of the lung]]. | ||
===SCC versus adenocarcinoma=== | |||
*p40 +ve. | |||
*CK5/6 +ve. | |||
*TTF-1 -ve. | |||
*[[Napsin]] -ve. | |||
===Lung SCC versus metastatic bladder urothelial carcinoma=== | |||
As per Gruver ''et al.'':<ref name=pmid23106579>{{Cite journal | last1 = Gruver | first1 = AM. | last2 = Amin | first2 = MB. | last3 = Luthringer | first3 = DJ. | last4 = Westfall | first4 = D. | last5 = Arora | first5 = K. | last6 = Farver | first6 = CF. | last7 = Osunkoya | first7 = AO. | last8 = McKenney | first8 = JK. | last9 = Hansel | first9 = DE. | title = Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. | journal = Arch Pathol Lab Med | volume = 136 | issue = 11 | pages = 1339-46 | month = Nov | year = 2012 | doi = 10.5858/arpa.2011-0575-OA | PMID = 23106579 }}</ref> | |||
{| class="wikitable sortable" | |||
! IHC | |||
! Lung <Br>SCC | |||
! Bladder <br>[[urothelial carcinoma|UCC]] | |||
|- | |||
| CK7 | |||
| 33% +ve | |||
| 100% +ve | |||
|- | |||
| CK20 | |||
| 7% +ve | |||
| 54% +ve | |||
|- | |||
| GATA-3 | |||
| 23% +ve | |||
| 78% +ve | |||
|- | |||
| Desmoglein-3 | |||
| 87% +ve | |||
| 11% +ve | |||
|- | |||
| CK14 | |||
| 77% +ve | |||
| 32% +ve | |||
|- | |||
| Uroplakin III | |||
| 0% +ve | |||
| 14% +ve | |||
|} | |||
==Sign out== | |||
<pre> | |||
Lung, Right Upper Lobe, Core Biopsy: | |||
- SQUAMOUS CELL CARCINOMA. | |||
COMMENT: | |||
The tumour stains as follows: | |||
POSITIVE: p40, CK5/6. | |||
NEGATIVE: TTF-1, napsin. | |||
</pre> | |||
===Block letters=== | |||
<pre> | |||
LUNG, RIGHT UPPER LOBE, BIOPSY: | |||
- INVASIVE SQUAMOUS CELL CARCINOMA. | |||
COMMENT: | |||
The tumour stains as follows: | |||
POSITIVE: p40, CK5/6. | |||
NEGATIVE: TTF-1, napsin. | |||
</pre> | |||
===Resection=== | |||
<pre> | |||
LUNG, RIGHT UPPER LOBE, LOBECTOMY: | |||
- SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED, pT2b, pN0. | |||
-- MARGINS NEGATIVE. | |||
-- PLEASE SEE TUMOUR SUMMARY. | |||
</pre> | |||
==See also== | ==See also== |
edits